Charpentier granted new CRISPR/Cas9 patent

23-04-2019

Charpentier granted new CRISPR/Cas9 patent

panuwach / Shutterstock.com

ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.


ERS Genomics, CRISPR, cas9, USPTO, Emmanuelle Charpentier, Broad Institute, gene editing

More on this story

ERS Genomics signs CRISPR deal with Lonza
14-12-2018

LSIPR